Education
About Us
Working with TipRanks
Follow Us
HeraMED Ltd. (DE:1I4)
FRANKFURT:1I4
1I4 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.01 - €0.04
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€5.89M
Enterprise Value€3.98M
Total Cash (Recent Filing)€1.96M
Total Debt (Recent Filing)$815.96K
Price to Earnings (P/E)―
Beta0.64
Next Earnings
Sep 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding875,602,700
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)2.92
Price to Sales (P/S)0.00
P/FCF Ratio-2.02
Enterprise Value/Market Cap0.67
Enterprise Value/Revenue11.21
Enterprise Value/Gross Profit28.47
Enterprise Value/Ebitda-2.84
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
HeraMED Ltd. News
PremiumCompany Announcements
HeraMED Ltd. Issues 6 Million Unquoted Options for Employee Incentive
PremiumCompany Announcements
HeraMED Ltd. Announces Cessation of Securities
PremiumCompany Announcements
HeraMED Ltd. Updates Corporate Constitution
PremiumCompany Announcements
HeraMED Refines US Strategy Amid Healthcare Policy Shifts
PremiumCompany Announcements
HeraMED Ltd. Initiates Trading Halt Ahead of Major Announcement
PremiumCompany Announcements
HeraMED Limited Schedules Annual General Meeting for May 2025
PremiumCompany Announcements
HeraMED Limited Announces AGM Date and Director Nomination Deadline1I4 FAQ
What was HeraMED Ltd.’s price range in the past 12 months?
HeraMED Ltd. lowest stock price was €0.01 and its highest was €0.04 in the past 12 months.
What is HeraMED Ltd.’s market cap?
HeraMED Ltd.’s market cap is €5.89M.
When is HeraMED Ltd.’s upcoming earnings report date?
HeraMED Ltd.’s upcoming earnings report date is Sep 02, 2025 which is in 37 days.
How were HeraMED Ltd.’s earnings last quarter?
Currently, no data Available
Is HeraMED Ltd. overvalued?
According to Wall Street analysts HeraMED Ltd.’s price is currently Overvalued.
Does HeraMED Ltd. pay dividends?
HeraMED Ltd. does not currently pay dividends.
What is HeraMED Ltd.’s EPS estimate?
HeraMED Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HeraMED Ltd. have?
HeraMED Ltd. has 875,602,700 shares outstanding.
What happened to HeraMED Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of HeraMED Ltd.?
Currently, no hedge funds are holding shares in DE:1I4
HeraMED Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
DE:1I4 Sentiment 57%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-321.94%
Trailing 12-Months
Asset Growth
47.03%
Trailing 12-Months
Company Description
HeraMED Ltd.
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a digital pregnancy monitor platform for the creation and implementation of digital health solutions for maternity care management. It also develops EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.
Uscom Limited
―
Atomo Diagnostics Ltd.
―
Adherium Ltd.
―
InhaleRx Limited
―
Control Bionics Ltd.
―